• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
In the last 7 days
Canakinumab by Novartis for Anemia: Likelihood of Approval Pharmaceutical Technology08:14 17-Jun-24
In the last month
Novartis seals triumphant return with first five-trancher International Financing Review09:09 6-Jun-24
Stats out for Novartis CHF2.2bn five-tranche International Financing Review12:08 5-Jun-24
Novartis prices CHF2.22bn five-tranche International Financing Review12:53 4-Jun-24
Novartis opens books on min CHF1.5bn five-tranche International Financing Review09:30 4-Jun-24
Novartis mandates CHF five-tranche, tbp today International Financing Review07:58 4-Jun-24
Novartis' radiotherapy drug Pluvicto gets nod in Korea Korea Biomedical Review07:48 29-May-24
Novartis City Heartbeat Index The Economist Intelligence Unit18:14 28-May-24
view more headlines
21 Jun 18:06

About our Novartis news

Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news.

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.